ARTICLE | Clinical News
Onsenal celecoxib regulatory update
April 11, 2011 7:00 AM UTC
The European Commission (EC) withdrew marketing authorization for Onsenal celecoxib from Pfizer to reduce the number of adenomatous intestinal polyps in familial adenomatous polyposis (FAP) as an adju...